The world’s richest man — Jeff Bezos — finds himself in a bizarre sort of controversy. Real-time prices are available during market hours (9:30 AM to 4:00 PM EST). ]There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Galmed Pharmaceuticals (GLMD), Biohaven Pharmaceutical ...[...]After Drug Failure, Genfit's Cupboard Is Nearly BareGalmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q1 2020 Results - Earnings Call TranscriptNon-Alcoholic Steatohepatitis Market Opportunities and Forecast (2020 – 2025) | Allergan PLC, Galmed Pharmaceuticals Ltd., Cadila Healthcare Ltd., Gemphire Therapeutics IncGalmed Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on Thursday August 6Nonalcoholic Steatohepatitis (NASH) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Non-Alcoholic Steatohepatitis Market Research 2020 by Industry Growth, Business Opportunities, Top Manufacture, Industry Share Report, Status, Regional Outlook and Global Forecast to 2026Nonalcoholic Steatohepatitis (NASH) Market 2020 Analysis report with Cross-Channel, Opportunities, Upturn Growth by 2026Nonalcoholic Steatohepatitis Therapeutics Market Poised to Expand at a Robust Pace by 2025Global Non-Alcoholic Steatohepatitis Management Market Advancements, Behaviour, Challenges, Opportunities, Top Companies and Forecast 2020-2026 | ALLERGAN, Zydus Cadila, Conatus Pharmaceuticals Inc, Galmed Pharmaceuticals Ltd, Gemphire Therapeutics, Genfit SA, Gilead Sciences, IncGlobal Non-Alcoholic Steatohepatitis (NASH) Drugs Market 2020 with Top Countries Data: Global Industry Trends, Market Size, Growth, Segmentation, Future Demands, Latest Innovation, Sales Revenue by Regional Forecast to 2026Non-Alcoholic Steatohepatitis (NASH) Market Growth-Analysis, Demand-Insight, Segmentation, Top-Manufacturers and Industry Forecast 2026Nonalcoholic Steatohepatitis Treatment Market 2020 Global Industry Demand, Share, Top Players, Industry Size, Future Growth by 2026 Research Reports WorldNonalcoholic Steatohepatitis (NASH) Market 2020 Global Industry Demand, Recent Trends, Size and Share Estimation by 2026 with Top Players by MarketReportsWorld.comNASH Therapeutic Drugs Market Size will Grow Profitably in the Near Future 2020-2026Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size will Grow Profitably in the Near Future 2020-2026Global Nonalcoholic Steatohepatitis Treatment Market 2020 Key Players, Industry Size, Share, Segmentation, Comprehensive Analysis and Forecast by 2025Non-alcoholic Steatohepatitis Market Set for Rapid Growth and Trend, by 2025Non-alcoholic Steatohepatitis Market Growth Analysis, Sales, Revenue, Gross Margin & Trend For Next 5 YearsNonalcoholic Steatohepatitis (NASH) Market 2020-2027: Boehringer Ingelheim, Cerenis Therapeutics, Connexios Life SciencesNon-alcoholic Steatohepatitis Market Business Growth With Top Players: ALLERGAN, Zydus Cadila, Conatus Pharmaceuticals Inc, Galmed Pharmaceuticals Ltd, Gemphire, Genfit SA, Gilead Sciences, IncNonalcoholic Steatohepatitis Market Global Research and Study by Experts 2020-2026: Novartis International, Shire, Cadila HealthcareNon-Alcoholic Steatohepatitis (NASH) Market Report 2020 Global Industry Statistics & Regional Outlook to 2026 Log in to see them here or sign up to get started.Create a list of the investments you want to track.Visit a quote page and your recently viewed tickers will be displayed here.On Wall Street, some things never change. Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. Why August in a pandemic is a time for vigilance for stock market investors Volume is also updated but is the delayed consolidated Volume from the symbol's exchange. Nash Holdings is ranked #22 on the Biggest Companies in Washington list. GLMD | Complete Galmed Pharmaceuticals Ltd. stock news by MarketWatch. Volume always reflects consolidated markets. Copyright © 2020 MarketWatch, Inc. All rights reserved. The Summary Quoteboard displays snapshot quote data.
Live educational sessions using site features to explore today's markets. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Click the "See More" link to see the full Performance Report page with expanded historical information.For comparison purposes, find information on other symbols contained in the same sector.View the latest top stories from the Associated Press or Canadian Press (based on your Market selection).